Cannabinoids in the Spotlight
17/10/2018
A contract commencing the cooperation between the Institute of Macromolecular Chemistry (IMC AS CR), the Institute of Organic Chemistry and Biochemistry (IOCB AS CR) and the Cannabis and Cannabinoids Institute (ICCI) was signed on Wednesday October 10, 2018. Research aims to develop iBodies® for selective recognition of cannabinoid receptors CB1/CB2 in tissue samples.
continue reading...NGAPA 2017
07/12/2017
iBodies® at the Next-Generation Antibodies and Protein Analysis conference in Gent, BE.
continue reading...iBodies® at Symposium of Biological Chemistry
07/12/2017
iBodies® technology presented at an international symposium in Linz, AT.
continue reading...iBodies® Technology at the EU-JAPAN Technology Helpdesk
22/06/2017
iBodies® technology is now presented via the EU-JAPAN Technology Helpdesk FOLLOW US ON: http://www.eu-jp-tthelpdesk.eu/technologies/ibodies-modular-polymer-based-synthetic-antibodies/
continue reading...iBodies® at the BIO International Convention in San Diego, CA
22/06/2017
Our team is currently presenting the iBody technology at the BIO International Convention in San Diego.
continue reading...